Tom Brady-backed telehealth AI startup eMed raises $200M, tops $2B valuation
eMed, a telehealth and digital health company, has raised $200 million in Series A funding, valuing the company at over $2 billion. The company, backed by Tom Brady, will use the funding to enhance its AI platform and launch a new care model.
eMed, a Miami-based telehealth company, has closed a $200 million Series A funding round. The company offers a health benefit platform with access to medications, at-home testing, and clinical support. eMed partners with employers to provide access to these services. The funding round was participated by several investors, including Tom Brady and Linda Yaccarino. eMed will use the funding to enhance its AI platform and launch a new care model. The company's platform is designed to provide structured, clinically supported programs for population health.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.